Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5653)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 27, 2024 (publication date) through Oct 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gupta T, Jarpula NS. Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status. World J Hepatol 2024; 16(3): 353-365 [PMID: 38577535 DOI: 10.4254/wjh.v16.i3.353] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i3/353.htm |
| Number | Citing Articles |
| 1 |
铭阳 唐. Current Research Status and Prospects of Immunotherapy Advances in Hepatocellular Carcinoma. Advances in Clinical Medicine 2025; 15(01): 254 doi: 10.12677/acm.2025.151037
|
| 2 |
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis. Immune Checkpoints and the Immunology of Liver Fibrosis. Livers 2025; 5(1): 5 doi: 10.3390/livers5010005
|
| 3 |
Maria Stella Franzè, Francesca Saffioti, Vasileios K. Mavroeidis. Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC. Cancer Drug Resistance 2025; doi: 10.20517/cdr.2024.212
|
| 4 |
Leonardo Stella, Giuseppe Cabibbo, Ciro Celsa, Roberta Ciccia, Alba Sparacino, Fabio Piscaglia, Francesco Tovoli, Andrea Arleo, Bernardo Stefanini, Massimo Iavarone, Roberta D'Ambrosio, Lucia Cerrito, Maria Pallozzi, Francesco Santopaolo, Fabio Marra, Claudia Campani, Chiara Mazzarelli, Raffaella Viganò, Raffaella Tortora, Alessio Aghemo, Stella De Nicola, Tiziana Pressiani, Lorenza Rimassa, Sherrie Bhoori, Salvatore Corallo, Laura Maiocchi, Andrea Martini, Caterina Soldà, Francesco Paolo Russo, Antonio Gasbarrini, Francesca Romana Ponziani. Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab. Liver International 2025; 45(10) doi: 10.1111/liv.70362
|
| 5 |
Xiang Li, Donghao Yin, Jiahao Geng, Yanyu Xu, Zijing Xu, Xuemeng Yang, Quanwei Li, Zimeng Shang, Zhiyun Yang, Zhong Xu, Jiabo Wang, Enxiang Zhang, Xinhua Song. Machine learning-driven multi-omics analysis identifies a prognostic gene signature associated with programmed cell death and metabolism in hepatocellular carcinoma. Biological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00286-1
|
| 6 |
Xiao-Wei Wang, Yu-Xing Tang, Fu-Xi Li, Jia-Le Wang, Gao-Peng Yao, Da-Tong Zeng, Yu-Lu Tang, Bang-Teng Chi, Qin-Yan Su, Lin-Qing Huang, Di-Yuan Qin, Gang Chen, Zhen-Bo Feng, Rong-Quan He. Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(10): 4244-4263 doi: 10.4251/wjgo.v16.i10.4244
Abstract(449) |
Core Tip(439) |
Full Article(HTML)(2195)
|
Full Article with Cover (PDF)-15821K(131)
|
Audio-2589K(4)
|
Peer-Review Report-181K(73)
|
Answering Reviewers-99K(81)
|
Supplementary Material-666K(73)
|
Full Article (PDF)-15497K(115)
|
Full Article (XML)-170K(75)
|
Times Cited (0)
|
Total Visits (5291)
|
Open
|